Skip to main content
Skip to main content
MCLE logo

Medicale Corp (MCLE) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0002 $0.00 (0.00%) |CouncilBullish Lean · 55 · B
Vol: 10.0K| 52-wk range: $0.0002 – $6.35
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Medicale Corp (MCLE) trades at $0.0002. Sector: Consumer defensive.

Price as of Sep 11, 2026 · Last analyzed: Mar 18, 2026
Medicale Corp., incorporated in 2020 and based in Wellington, Florida, is a subsidiary of Magenta Acres Inc. The company intends to distribute dietary supplements and provide consulting services, but currently has no significant operations.

Analyst Coverage for MCLE: MCLE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MCLE against Consumer Defensive peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the MCLE film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 55/100 · B

MCLE: 1/2 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Simons-style lens (simulated)Jim Simons
Favorable read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Medicale Corp (MCLE) Consumer Business Overview

Employees1
HeadquartersWellington, United States

Medicale Corp., a subsidiary of Magenta Acres Inc., is a pre-operational company in the consumer defensive sector, intending to enter the food distribution industry with dietary supplements and consulting services. Based in Wellington, Florida, the company currently lacks significant business activity and faces challenges in establishing its market presence.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for MCLE?

AI-written as of Mar 18, 2026 — figures and tone reflect the data available then, not today's score.

Medicale Corp. presents a speculative investment opportunity due to its pre-operational status and lack of significant business activity as of March 18, 2026. The company's intention to distribute dietary supplements and offer consulting services in the consumer defensive sector is yet to be realized. Key value drivers would depend on successful market entry, establishing distribution channels, and building a customer base. Growth catalysts include effective execution of its business plan and leveraging the support of its parent company, Magenta Acres Inc. Potential risks include the competitive landscape of the food distribution and consulting sectors, the company's ability to secure funding, and the uncertainty of transitioning from a pre-operational state to a functioning business. Given the absence of financial data and operational metrics, assessing the company's intrinsic value is challenging.

Based on FMP financials and quantitative analysis

MCLE Key Highlights

AI-written as of Mar 18, 2026 — figures and tone reflect the data available then, not today's score.

Medicale Corp. was incorporated in 2020, indicating a relatively young company.

  • The company is a subsidiary of Magenta Acres Inc., potentially providing access to resources and support.
  • Medicale Corp. intends to operate in the consumer defensive sector, specifically targeting the food distribution industry.
  • The company's business plan involves the distribution of dietary supplements and the provision of consulting services.
  • As of 2026, Medicale Corp. does not have significant operations, indicating it is in the early stages of development.

Who Are MCLE's Competitors?

MCLE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
SYY Sysco Corporation $82.31 +0.91% $39.4B 695-pillar
USFD I am unable to provide a company dossier for USFD because there $95.34 -0.75% $21.0B 705-pillar
PFGC Performance Food Group Company $94.83 +0.50% $14.9B 605-pillar
BZLFY Bunzl plc $17.39 -2.41% $5.83B 449-signal
CHEF The Chefs' Warehouse, Inc. $110.89 +1.02% $4.52B 775-pillar
UNFI United Natural Foods, Inc. $44.11 -1.12% $2.67B 725-pillar
ANDE The Andersons, Inc. $71.88 +0.79% $2.45B 675-pillar
AVO Mission Produce, Inc. $13.24 -1.34% $1.17B 615-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are MCLE's Key Strengths?

Subsidiary of Magenta Acres Inc.

  • Focus on the growing dietary supplements market.
  • Intention to offer consulting services.

What Are MCLE's Weaknesses?

Pre-operational status with no significant business activity.

  • Lack of established distribution channels.
  • Limited brand recognition.

What Could Drive MCLE Stock Higher?

Launch of dietary supplement products.

  • Establishment of distribution channels.
  • Development of online presence and e-commerce platform.

What Are the Key Risks for MCLE?

Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.

  • Intense competition in the dietary supplement market.
  • Regulatory hurdles and compliance requirements.
  • Economic downturn affecting consumer spending.
  • Uncertainty of transitioning from pre-operational to operational status.

What Are the Growth Opportunities for MCLE?

  • Growth opportunity 1: Expanding the dietary supplement product line. Medicale Corp. can explore opportunities to introduce new and innovative dietary supplements to cater to evolving consumer preferences. The global dietary supplements market is projected to reach $230.73 billion by 2027, growing at a CAGR of 8.6% from 2020. Successfully launching new products could drive revenue growth and market share. Timeline: Within the next 2-3 years.
  • Growth opportunity 2: Developing a strong online presence and e-commerce platform. With the increasing trend of online shopping, Medicale Corp. can capitalize on this by establishing a robust e-commerce platform to sell its dietary supplements directly to consumers. The global e-commerce market is expected to reach $6.54 trillion in 2023. A user-friendly website and effective digital marketing strategies can drive online sales. Timeline: Within the next 1-2 years.
  • Growth opportunity 3: Forming strategic partnerships with retailers and distributors. Collaborating with established retailers and distributors can provide Medicale Corp. with access to a wider customer base and distribution network. This can help the company to quickly scale its operations and increase its market reach. Timeline: Ongoing.
  • Growth opportunity 4: Offering personalized consulting services. Medicale Corp. can differentiate itself by providing personalized consulting services related to dietary supplements and wellness. This can involve offering customized recommendations based on individual health needs and goals. The personalized nutrition market is growing, driven by increasing consumer interest in tailored health solutions. Timeline: Within the next 1-2 years.
  • Growth opportunity 5: Expanding into international markets. Once Medicale Corp. has established a strong presence in the domestic market, it can explore opportunities to expand into international markets. The global dietary supplements market is growing in regions such as Asia-Pacific and Europe. This can provide the company with significant growth potential. Timeline: Within the next 3-5 years.

What Threats Does MCLE Face?

  • Highly competitive food distribution and dietary supplement industry.
  • Regulatory changes affecting the dietary supplement market.
  • Economic downturn impacting consumer spending on non-essential goods.

What Are MCLE's Competitive Advantages?

  • Potential access to resources and support from parent company, Magenta Acres Inc.
  • Focus on the growing dietary supplements market.
  • Intention to offer personalized consulting services for differentiation.

What Does MCLE Do?

Medicale Corp. was incorporated in 2020 and is based in Wellington, Florida. As a subsidiary of Magenta Acres Inc., Medicale Corp. intends to operate within the consumer defensive sector, specifically targeting the food distribution industry. The company's stated business plan involves the distribution of dietary supplements and the provision of consulting services. However, as of 2026, Medicale Corp. does not have significant operations, indicating that it is still in the initial stages of development and market entry. The company's focus on dietary supplements aligns with the broader health and wellness trend within the consumer market. The consulting services aspect suggests a potential diversification strategy, possibly aimed at providing expertise related to the dietary supplement industry or broader health and wellness topics. Given its current lack of operations, Medicale Corp.'s success will depend on its ability to effectively execute its business plan, establish distribution channels, and build a customer base. The backing of Magenta Acres Inc. could provide financial and strategic support, but the company will still need to navigate the competitive landscape of the food distribution and consulting sectors. The company's future trajectory remains uncertain, contingent on its ability to transition from a pre-operational state to a functioning business with revenue generation and market presence.

What Products and Services Does MCLE Offer?

  • Intends to distribute dietary supplements.
  • Plans to provide consulting services.
  • Aims to operate in the consumer defensive sector.
  • Targets the food distribution industry.
  • Functions as a subsidiary of Magenta Acres Inc.

How Does MCLE Make Money?

  • Distribute dietary supplements to consumers through various channels.
  • Offer consulting services related to health and wellness.
  • Generate revenue through the sale of dietary supplements and consulting fees.

What Industry Does MCLE Operate In?

Medicale Corp. intends to operate in the consumer defensive sector, specifically within the food distribution industry, focusing on dietary supplements. This sector is characterized by relatively stable demand, as consumers tend to maintain spending on essential goods and services regardless of economic conditions. The market for dietary supplements is growing, driven by increasing health awareness and an aging population. However, the industry is also highly competitive, with numerous established players and new entrants. Medicale Corp.'s success will depend on its ability to differentiate itself, establish effective distribution channels, and build brand recognition in a crowded market.

Who Are MCLE's Key Customers?

  • Individuals seeking dietary supplements for health and wellness.
  • Consumers interested in personalized consulting services.
  • Retailers and distributors of dietary supplements.
Model self-rating on this text: 60% (not a measure of the evidence) Updated: Mar 18, 2026

Research confidence

Low 20/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • No filing on record
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 46
2026-08-26 46
2026-08-29 46
2026-09-01 46
2026-09-04 46
2026-09-07 46
2026-09-10 46

What changed?

The score has stayed at 46.

Over the same 18 days the stock moved +0.0%.

F-Score 2/9

Financial Health

Medicale Corp's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

ROE 25%

Key Financial Metrics

Return on equity for Medicale Corp stands at 25.1%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -4.7%, a gauge of the cash the business throws off relative to its market value. Its earnings yield is -8.0%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

Medicale Corp operates in the Food Distribution industry within the Consumer Defensive sector. It is headquartered in Wellington, US. The company is led by CEO Chen Zu De. MCLE has traded publicly since 2022.

MCLE Financials

Fundamental Snapshot

Net Income Growth (FY)
+29.3%
EPS Growth (FY)
+28.6%
Free Cash Flow Growth (FY)
+72.5%
Return on Equity (TTM)
+25.1%

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Subsidiary of Magenta Acres Inc.
  • Focus on the growing dietary supplements market.
  • Intention to offer consulting services.
  • Upcoming: Launch of dietary supplement products.

Bear Case

  • Pre-operational status with no significant business activity.
  • Lack of established distribution channels.
  • Limited brand recognition.
  • Potential: Intense competition in the dietary supplement market.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

MCLE Latest News

No recent news available for MCLE.

MCLE Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MCLE.

Price Targets

Wall Street price target analysis for MCLE.

MCLE MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MCLE; grades run from A+ (80-100) to F (below 30).

MCLE OTC Market Information

MCLE trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

Medicale Corp Consumer Defensive Stock: Key Questions Answered

Is MCLE a good stock?

Stock Expert AI does not rate MCLE buy, sell or hold. Medicale Corp has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about MCLE stock?

As of March 18, 2026, there is no available analyst coverage or consensus on Medicale Corp. (MCLE) stock. This is primarily due to the company's pre-operational status and lack of significant business activity.

What are the key factors to evaluate for MCLE?

Evaluate MCLE on fundamentals, analyst consensus, and risk factors. Key value drivers would depend on successful market entry, establishing distribution channels, and building a customer base. Not financial advice.

How frequently does MCLE data refresh on this page?

MCLE's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven MCLE's recent stock price performance?

Medicale Corp (MCLE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Subsidiary of Magenta Acres Inc. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider MCLE overvalued or undervalued right now?

Medicale Corp (MCLE) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of MCLE?

Yes, most major brokerages offer fractional shares of Medicale Corp (MCLE) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track MCLE's earnings and financial reports?

Medicale Corp (MCLE) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for MCLE earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is limited due to the company's pre-operational status.
  • Financial data is unavailable.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover